PMS2 and endometrioid adenocarcinoma: To explain the heterogeneity of results, we hypothesized that the relationship between the FIGO grade of endometrioid adenocarcinomas and PD-L1 expression may be mediated by MLH1/PMS2 loss because MMR deficiency is common in high-grade endometrioid adenocarcinomas [21].